Search

Search Constraints

You searched for: Author/Creator Vivaldi, C

Search Results

1. 169PSelective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancer. (23rd October 2018)

2. 764PAdvanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience. (23rd October 2018)

3. 765PPrediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations. (23rd October 2018)

4. HIV DNA reservoir and elevated PD‐1 expression of CD4 T‐cell subsets particularly persist in the terminal ileum of HIV‐positive patients despite cART. Issue 5 (9th January 2021)

5. P-054Predicting HER2 status in esophagogastric cancer: Development and validation of an easy-to-use nomogram. (20th June 2018)

6. P-054Predicting HER2 status in esophagogastric cancer: Development and validation of an easy-to-use nomogram. (20th June 2018)

7. P-159Analysis of early tumor shrinkage and depth of response in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX or gemcitabine + nab-paclitaxel. (20th June 2018)

8. P-279Characterization of mismatch repair deficiency in biliary tract cancer. (2nd July 2019)

9. P-299Baseline computed-tomography (CT)-evaluated sarcopenia predicts toxicity from first-line chemotherapy in metastatic gastric cancer (mGC) patients. (2nd July 2019)

10. P-319Longitudinal evaluation of angiogenesis-related circulating biomarkers during second-line treatment with paclitaxel and ramucirumab in advanced gastroesophageal cancer. (2nd July 2019)